Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Behavioral: TIP / IMPACT Plus Care Coordination----3件: 46, 96, 97
2PREVENAR 13 - 0.5 ML SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - FLACONCINO MONODOSE (0,5 ML VETRO TIPO I) - 1 FLACONCINO MONODOSE1件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen---1件: 222
3TIP----1件: 299
4TIP (Tobramycin inhalation powder)1件: Tobramycin2件: D00063 ,
D02542
--1件: 299
5Tipelukast1件: Tipelukast1件: D06659 (Name: Tipelukast)1件: CYSLTR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 85
6Tipifarnib1件: Tipifarnib1件: D03720 (Name: Tipifarnib)2件: FNTA,
FNTB 💬
1件: Terpenoid backbone biosynthesis 💬1件: 34
7Tipranavir1件: Tipranavir2件: D03843 (Name: Tipranavir disodium),
D08605 (Name: Tipranavir)
--1件: 265
8TIS or TIP----1件: 299
9Tobramycin Inhalation Powder (TIP)1件: Tobramycin2件: D00063 ,
D02542
--1件: 299
10Tobramycin Inhalation Powder TIP delivered by the T-326 Inhaler1件: Tobramycin2件: D00063 ,
D02542
--1件: 299